Radiologic Score and Failure of Conservative Management of Adhesive Small Bowel Obstruction (PREDIFAIL)

August 24, 2022 updated by: University Hospital, Angers

Assessment of a Predictive Radiologic Score to Predict the Failure of the Non-operative Management of Adhesive Small Bowel Obstruction: a Prospective Cohort Analysis

The management of acute adhesive small bowel obstruction remains challenging for the digestive surgeon. The Bologna guidelines recommend that conservative management of aSBO. The literature reports that this form of management has a failure rate between 10 and 40%.

A radiological score has been proposed and was associated with an increased risk of failure of conservative management.

This tool is promising to select patients further requiring surgery but it has to be assessed in a multi centric prospective cohort.

Study Overview

Study Type

Observational

Enrollment (Actual)

279

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Angers, France
        • University Hospital of Angers

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (ADULT, OLDER_ADULT)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

All

Sampling Method

Non-Probability Sample

Study Population

This was an observational multicentric cohort study including all the consecutive patients admitted for initial non-surgical management for aSBO. The study took place over a period of 3 months (September 15 - December 15, 2021) in 15 French centers.

Description

Inclusion Criteria:

  • all the consecutive patients admitted for initial non-surgical management for aSBO
  • during the period of inclusion

Exclusion Criteria:

  • the cause of SBO was functional or other than adhesive
  • patients requiring initial surgical management.
  • absence of computed tomography performed at admission

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
success of the medical management
Patients that recovered flatus and stools, and that tolerated solid food within the 3 days after the admission
failure of the medical management
Patients that did not recover flatus and stools, and that did not tolerate solid food within the 3 days after the admission. These patients had an indication for surgery.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Angers CT score
Time Frame: immediately after the completion of the CT-scan

The Angers CT score ≥5 was considered to be risk factor for failure of the medical management.

Angers CT score was calculated by reading the CT scan as follow:

  • beak sign (+2), if not (0)
  • closed loop (+4), if not (0)
  • focal (+4) or diffuse (+4) intraperitoneal liquid, if not (0)
  • focal (+2) or diffuse (0) mesenteric haziness, if not (0)
  • focal (-3) or diffuse (-3) mesenteric liquid, if not (0)
  • diameter of the most dilated small bowel loop > 40 mm (-2) (if not (0).
immediately after the completion of the CT-scan

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (ACTUAL)

September 15, 2021

Primary Completion (ACTUAL)

December 15, 2021

Study Completion (ACTUAL)

January 15, 2022

Study Registration Dates

First Submitted

August 20, 2022

First Submitted That Met QC Criteria

August 24, 2022

First Posted (ACTUAL)

August 26, 2022

Study Record Updates

Last Update Posted (ACTUAL)

August 26, 2022

Last Update Submitted That Met QC Criteria

August 24, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 2021-099

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Small Bowel Obstruction

3
Subscribe